Sort Through Meds for Managing Hemophilia

New meds Jivi (JIH-vee) and Rebinyn (reh-bee-NYNE) will raise questions about managing bleeding in hemophilia patients.

Jivi (recombinant PEGylated factor VIII) will be for hemophilia A. It will compete with other long-acting (Adynovate, Eloctate, etc) and short-acting (Kogenate FS, Recombinate, etc) factor VIII products.

Rebinyn (recombinant glycoPEGylated factor IX) is for the less common hemophilia B. It's an alternative to long-acting (Alprolix, Idelvion, etc) or short-acting (BeneFix, Ixinity, etc) factor IX products.